Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication201220132014201520162017201820192020202120222023202420252026 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyProduct Development Unit Sep 2025 Lancet Infect Dis Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial Autoren Agnandji ST et al. Sep 2025 J Virol A novel accessory gene product of tick-borne Dhori-Orthomyxovirus, encoded by overlooked spliced transcripts of RNA segment 6 Autoren Bendl E et al. Sep 2025 Mucosal Immunol Akkermansia muciniphila ameliorates Salmonella-induced colitis and intestinal fibrosis Autoren Suwandi A et al. Sep 2025 Front Vet Sci On-site detection of MERS-CoV infections in a camel slaughterhouse in Kenya using a commercial rapid antigen test Autoren Ogoti BM et al. Sep 2025 Open Forum Infect Dis Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study Autoren Thompson GR et al. Sep 2025 mBio Aspergillus fumigatus effector crpA orchestrates host prostaglandin signaling to promote fungal virulence Autoren Pinzan CF et al. Sep 2025 Lancet Child Adolesc Health Childhood tuberculosis: robust funding and integrated solutions needed now Autoren Mandalakas AM Casenghi M Zwerling A Sep 2025 mBio Humoral immunity to current variants of SARS-CoV-2 in exposed adults, September 2023 to September 2024 Autoren Jeworowski LM et al. Sep 2025 PLoS One Whole blood RNA profiling in cats dissects the host immunological response during recovery from feline infectious peritonitis Autoren Zwicklbauer K et al. Sep 2025 Clin Microbiol Infect High rates of acquired resistance to fluoroquinolones, bedaquiline and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova Autoren Chesov D et al. Sep 2025 Z Gastroenterol Quality of life improves during antiviral therapy with bulevirtide Autoren Eichholz JC et al. Sep 2025 Mult Scler Severe course of tick-borne encephalitis (TBE) in a patient with relapsing multiple sclerosis (MS) treated with ocrelizumab Autoren Gernert JA et al. Sep 2025 J Ethnopharmacol Toxicity profile, antiplasmodial and gametocytocidal properties of Erigeron bonariensis L. (anc. Conyza bonariensis (L.) Cronquist) Autoren Lahngong MS et al. Sep 2025 Bioinformatics TransFactor-prediction of pro-viral SARS-CoV-2 host factors using a protein language model Autoren An Y et al. Sep 2025 NPJ Biofilms Microbiomes Metatranscriptomics-based metabolic modeling of patient-specific urinary microbiome during infection Autoren Josephs-Spaulding J et al. Sep 2025 BMJ Open Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial) Autoren Rauber C et al. Sep 2025 BMC Public Health The interplay of influenza and COVID-19 in Germany, January 2020 - December 2022: a study of competitive disease dynamics with quarantine measures and partial cross-immunity Autoren Fome AD et al. Sep 2025 Inn Med (Heidelb) [Helicobacter pylori] Autoren Schulz C Schütte K Sep 2025 PLoS Pathog Fexinidazole and Corallopyronin A target Wolbachia-infected sheath cells present in filarial nematodes Autoren Chappell L et al. Sep 2025 Int J Epidemiol Malaria amidst the COVID-19 pandemic in Gabon: an application of autoregressive integrated moving average (ARIMA) models within an interrupted time series (ITS) framework to hospital-based data Autoren Roeder F et al. Sep 2025 Clin Microbiol Rev Proteus spp.-taxonomy, clinical significance, and antibiotic resistance of a highly versatile pathogen Autoren Muhsal LK et al. Sep 2025 J Med Chem Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity Autoren Klein S et al. Sep 2025 Int J Antimicrob Agents Cross-border dialogue: An international survey of regulators on phage therapy Autoren Alvarez RD et al. Sep 2025 Microbiol Spectr Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant Acinetobacter baumannii detected from ICU admission screening in Hanoi, Vietnam, 2023 Autoren Boutin S et al. Sep 2025 mBio The Helicobacter pylori orphan ATTAAT-specific methyltransferase M.Hpy99XIX plays a central role in the coordinated regulation of genes involved in iron metabolism Autoren Gottschall W et al. Pagination Previous page ‹‹ Seite 3 Seite 4 Seite 5 Seite 6 Current page 7 Seite 8 Seite 9 Seite 10 Seite 11 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 10 Seite 11 Next page ››
Sep 2025 Lancet Infect Dis Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial Autoren Agnandji ST et al.
Sep 2025 J Virol A novel accessory gene product of tick-borne Dhori-Orthomyxovirus, encoded by overlooked spliced transcripts of RNA segment 6 Autoren Bendl E et al.
Sep 2025 Mucosal Immunol Akkermansia muciniphila ameliorates Salmonella-induced colitis and intestinal fibrosis Autoren Suwandi A et al.
Sep 2025 Front Vet Sci On-site detection of MERS-CoV infections in a camel slaughterhouse in Kenya using a commercial rapid antigen test Autoren Ogoti BM et al.
Sep 2025 Open Forum Infect Dis Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study Autoren Thompson GR et al.
Sep 2025 mBio Aspergillus fumigatus effector crpA orchestrates host prostaglandin signaling to promote fungal virulence Autoren Pinzan CF et al.
Sep 2025 Lancet Child Adolesc Health Childhood tuberculosis: robust funding and integrated solutions needed now Autoren Mandalakas AM Casenghi M Zwerling A
Sep 2025 mBio Humoral immunity to current variants of SARS-CoV-2 in exposed adults, September 2023 to September 2024 Autoren Jeworowski LM et al.
Sep 2025 PLoS One Whole blood RNA profiling in cats dissects the host immunological response during recovery from feline infectious peritonitis Autoren Zwicklbauer K et al.
Sep 2025 Clin Microbiol Infect High rates of acquired resistance to fluoroquinolones, bedaquiline and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova Autoren Chesov D et al.
Sep 2025 Z Gastroenterol Quality of life improves during antiviral therapy with bulevirtide Autoren Eichholz JC et al.
Sep 2025 Mult Scler Severe course of tick-borne encephalitis (TBE) in a patient with relapsing multiple sclerosis (MS) treated with ocrelizumab Autoren Gernert JA et al.
Sep 2025 J Ethnopharmacol Toxicity profile, antiplasmodial and gametocytocidal properties of Erigeron bonariensis L. (anc. Conyza bonariensis (L.) Cronquist) Autoren Lahngong MS et al.
Sep 2025 Bioinformatics TransFactor-prediction of pro-viral SARS-CoV-2 host factors using a protein language model Autoren An Y et al.
Sep 2025 NPJ Biofilms Microbiomes Metatranscriptomics-based metabolic modeling of patient-specific urinary microbiome during infection Autoren Josephs-Spaulding J et al.
Sep 2025 BMJ Open Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial) Autoren Rauber C et al.
Sep 2025 BMC Public Health The interplay of influenza and COVID-19 in Germany, January 2020 - December 2022: a study of competitive disease dynamics with quarantine measures and partial cross-immunity Autoren Fome AD et al.
Sep 2025 PLoS Pathog Fexinidazole and Corallopyronin A target Wolbachia-infected sheath cells present in filarial nematodes Autoren Chappell L et al.
Sep 2025 Int J Epidemiol Malaria amidst the COVID-19 pandemic in Gabon: an application of autoregressive integrated moving average (ARIMA) models within an interrupted time series (ITS) framework to hospital-based data Autoren Roeder F et al.
Sep 2025 Clin Microbiol Rev Proteus spp.-taxonomy, clinical significance, and antibiotic resistance of a highly versatile pathogen Autoren Muhsal LK et al.
Sep 2025 J Med Chem Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity Autoren Klein S et al.
Sep 2025 Int J Antimicrob Agents Cross-border dialogue: An international survey of regulators on phage therapy Autoren Alvarez RD et al.
Sep 2025 Microbiol Spectr Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant Acinetobacter baumannii detected from ICU admission screening in Hanoi, Vietnam, 2023 Autoren Boutin S et al.
Sep 2025 mBio The Helicobacter pylori orphan ATTAAT-specific methyltransferase M.Hpy99XIX plays a central role in the coordinated regulation of genes involved in iron metabolism Autoren Gottschall W et al.
